㈜엠디뮨은 비전과 열정으로 신약 개발을 통해 세상을 바꾸어 가고 섬기는 일에 앞장서겠습니다.
Employees: 11-50
Founded date: 2015
Investors 3
| Date | Name | Website |
| - | Startup Cr... | startupcre... |
| 14.01.2021 | Plug and P... | plugandpla... |
| - | InterValue... | intervalue... |
Mentions in press and media 4
| Date | Title | Description |
| 22.02.2023 | MDimune Named as a Finalist in the Prestigious 2023 Edison Awards™ | BioDroneTM next-generation drug delivery platform honored for excellence alongside other innovators and innovations in the Health, Medical & Biotech category SEONGDONG-GU, SEOUL, SOUTH KOREA, February 22, 2023 /EINPresswire.com/ -- MDim... |
| 26.01.2023 | MDimune announces a collaboration with Hanyang University on the projects selected through the 3rd BioDrone™ Award | SEONGDONG-GU, SEOUL, SOUTH KOREA, January 26, 2023 /EINPresswire.com/ -- MDimune Inc., a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announces funding of two research projects focus... |
| 05.01.2023 | MDimune announced the development of the GMP manufacturing process for cell-derived vesicles in the latest publication | SEONGDONG-GU, SEOUL, SOUTH KOREA, January 5, 2023 /EINPresswire.com/ -- MDimune Inc., a Korean biotech company developing BioDrone™ platform technology based on cell-derived vesicles (CDVs), announced the publication of data in the Journal ... |
| 07.12.2022 | MDimune Inc. enters into a Research Collaboration Agreement with ANU to develop therapeutics for AMD | SEONGDONG-GU, SEOUL, SOUTH KOREA, December 7, 2022 /EINPresswire.com/ -- MDimune Inc., a Korean biotech company developing BioDroneTM platform technology based on cell-derived vesicles (CDVs), announced a research collaboration agreement wi... |